Jordi Quintana

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 4

Top Topics

Cerebrospinal Fluid

Cognitive Decline

Top Venues

International journal of molecular sciences

Scientific reports

Journal of medicinal chemistry

Universitat Pompeu Fabra

University of California Los Angeles (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universitat Pompeu Fabra Sep 01 2017

Spain

Senior Researcher :: Research Programme on Biomedical Informatics

Parc Científic Barcelona Jun 05 2007 - Jun 01 2017

Spain

Head :: Drug Discovery Platform

Education History

University of California Los Angeles Sep 14 1986 - Jun 14 1991

United States

PHD :: Chemistry & Biochemistry

Publications

Tiago Gião, Joana Saavedra, Ellen Cotrina, Jordi Quintana, Jordi Llop, Gemma Arsequell, Isabel Cardoso
Undiscovered Roles for Transthyretin: From a Transporter Protein to a New Therapeutic Target for Alzheimer's Disease. International journal of molecular sciences 21 (6) (2020)
Ellen Y Cotrina, Ana Gimeno, Jordi Llop, Jiménez-Barbero Jesús, Jordi Quintana, Gregorio Valencia, Isabel Cardoso, Rafel Prohens, Gemma Arsequell
Calorimetric Studies of Binary and Ternary Molecular Interactions between Transthyretin, Aβ Peptides, and Small-Molecule Chaperones toward an Alternative Strategy for Alzheimer's Disease Drug Discovery. Journal of medicinal chemistry 63 (6) (2020)
Ellen Y Cotrina, Ângela Oliveira, José Pedro Leite, Jordi Llop, Ângela Inácio, Jordi Quintana, Isabel Cardoso, Gemma Arsequell
Repurposing Benzbromarone for Familial Amyloid Polyneuropathy: A New Transthyretin Tetramer Stabilizer. International journal of molecular sciences 21 (19) (2020)
Xabier Rios, Vanessa Gómez-Vallejo, Abraham Martín, Unai Cossío, Miguel Ángel Morcillo, Mobina Alemi, Isabel Cardoso, Jordi Quintana, Jiménez-Barbero Jesús, Ellen Y Cotrina, Gregorio Valencia, Gemma Arsequell, Jordi Llop
Radiochemical examination of transthyretin (TTR) brain penetration assisted by iododiflunisal, a TTR tetramer stabilizer and a new candidate drug for AD. Scientific reports 9 (1) (2019)